Supplementary Table S5 from An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers — Boris Guyot | RDL Network
Supplementary Table S5 from An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers
Dataset en
Authors
BG
Boris Guyot
FC
Flora Clément
YD
Youenn Drouet
Abstract
1 min read
<p>Supplementary Table S5 shows the drugs corresponding to the targets indicated in Figures 2K and 5E of the main text.</p>
Discussion(0)
No comments yet. Be the first to comment.